Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q3 EPS of ($0.13), $0.01 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $13.54 million versus the consensus estimate of $12.74 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.